DPharm: Disruptive Clinical Trials - September 17-18, 2019 - Boston, MA

DPharm presents quality leadership from all levels of the industry to share what they have learned in driving innovation with the goal of modernizing 21st century drug development.

Dr Scott Gottlieb, 23rd Commissioner of the FDA, will open DPharm with his view on modernizing clinical trials and specifically on what we should be prioritizing, the main theme for the 2019 event, which more than 500 executives are expected to attend.

2019 Topics Include:
- Real World Data to Create Trial Readiness Cohorts
- Gaining Independence of Randomized Clinical Trials
- Operationalizing EHR-Enabled eSource
- Patient Data Access and Ownership
- Master Protocols
- Digital Biomarkers
- Modernizing Clinical Endpoints
- Protocol Simulation
- Flexible Clinical Trials and Getting to the Next Level
- Using Historical Data to Transform Clinical Trials
- Incorporating External Innovation in Transforming Clinical Trials
- Creating a Culture to Support Innovation
- Big Data and AI
- Meeting the Needs of the Patients of the Future
- Cyber Security and Ethical Hacking

4 Essential Track Choices:
- Big Data Management and AI: How One will Lead to the Other, What to Expect and How to Prepare
- Workforce Innovation: Upskilling Site Staff for 21st C Clinical Trials with ACRP
- CRAACO: Clinical Research as a Care Option
- Patient-Centered Trials

From experienced radical thinkers to those new in the trenches, all are welcome! 

Others Details

Time: 8:00 am - 6:00 pm